New pill could help babies breathe easier from RSV
Disease control
Not yet recruiting
This study tests a new oral drug called zelicapavir in children aged 28 days to 36 months who have RSV infection. The drug aims to stop the virus from multiplying and help symptoms clear faster. About 150 children will participate, and the study compares the drug to a placebo to …
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated May 01, 2026 16:01 UTC